Oyster Point Pharma Inc

Company Profile

Oyster Point Pharma Inc had its IPO on 2019-10-31 under the ticker symbol OYST.

The company operates in the Healthcare sector and Biotechnology & Medical Research industry. Oyster Point Pharma Inc has a staff strength of 303 employees.

Stock update

Shares of Oyster Point Pharma Inc opened at $11.16 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $11.12 - $11.2, and closed at $11.17.

This is a +0.18% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Oyster Point Pharma Inc have increased by +0.81%.

Oyster Point Pharma Inc's Key Ratios

Oyster Point Pharma Inc has a market cap of $299.85 million, indicating a price to book ratio of 2.3909 and a price to sales ratio of 15.2699.

In the last 12-months Oyster Point Pharma Inc’s revenue was $19.58 million with a gross profit of $23.01 million and an EBITDA of $-158142000. The EBITDA ratio measures Oyster Point Pharma Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Oyster Point Pharma Inc’s operating margin was -809.09% while its return on assets stood at -65.11% with a return of equity of -306.38%.

In Q3, Oyster Point Pharma Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 68.8%.

Oyster Point Pharma Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-4.946 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Oyster Point Pharma Inc’s profitability.

Oyster Point Pharma Inc stock is trading at a EV to sales ratio of 16.6346 and a EV to EBITDA ratio of -1.9863. Its price to sales ratio in the trailing 12-months stood at 15.2699.

Oyster Point Pharma Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$109.20 million

Total Liabilities

$29.20 million

Operating Cash Flow

$0

Capital Expenditure

$85000

Dividend Payout Ratio

0%

Oyster Point Pharma Inc ended 2024 with $109.20 million in total assets and $0 in total liabilities. Its intangible assets were valued at $109.20 million while shareholder equity stood at $-22202000.00.

Oyster Point Pharma Inc ended 2024 with $300000.00 in deferred long-term liabilities, $29.20 million in other current liabilities, 27000.00 in common stock, $-389991000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $68.80 million and cash and short-term investments were $68.80 million. The company’s total short-term debt was $692,000 while long-term debt stood at $92.22 million.

Oyster Point Pharma Inc’s total current assets stands at $97.71 million while long-term investments were $886000.00 and short-term investments were $0. Its net receivables were $13.18 million compared to accounts payable of $4.15 million and inventory worth $6.96 million.

In 2024, Oyster Point Pharma Inc's operating cash flow was $0 while its capital expenditure stood at $85000.

Comparatively, Oyster Point Pharma Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$11.17

52-Week High

$11.83

52-Week Low

$5.17

Analyst Target Price

$27.5

Oyster Point Pharma Inc stock is currently trading at $11.17 per share. It touched a 52-week high of $11.83 and a 52-week low of $11.83. Analysts tracking the stock have a 12-month average target price of $27.5.

Its 50-day moving average was $8.25 and 200-day moving average was $6.8 The short ratio stood at 1.54 indicating a short percent outstanding of 0%.

Around 148.5% of the company’s stock are held by insiders while 8732.4% are held by institutions.